28536535|t|Role of Intestinal LXRα in Regulating Post-prandial Lipid Excursion and Diet - Induced Hypercholesterolemia and Hepatic Lipid Accumulation
28536535|a|Post-prandial hyperlipidemia has emerged as a cardiovascular risk factor with limited therapeutic options. The Liver X receptors (Lxrs) are nuclear hormone receptors that regulate cholesterol elimination. Knowledge of their role in regulating the absorption and handling of dietary fats is incomplete. The purpose of this study was to determine the role of intestinal Lxrα in post-prandial intestinal lipid transport. Using Lxrα knockout (nr1h3(-/-)) and intestine - limited Lxrα over-expressing [Tg(fabp2a: EGFP - nr1h3)] zebrafish strains, we measured post-prandial lipid excursion with live imaging in larvae and physiological methods in adults. We also conducted a long-term high - cholesterol dietary challenge in adults to examine the chronic effect of modulating nr1h3 gene dose on the development of hypercholesterolemia and hepatic lipid accumulation. Over-expression of Lxrα in the intestine delays the transport of ingested lipids in larvae, while deletion of Lxrα increases the rate of lipid transport. Pre-treating wildtype larvae with the liver-sparing Lxr agonist hyodeoxycholic acid also delayed the rate of intestinal lipid transport in larvae. In adult males, deletion of Lxrα accelerates intestinal transport of ingested lipids. Adult females showed higher plasma Lipoprotein lipase (Lpl) activity compared to males, and lower post-gavage blood triacylglycerol (TAG) excursion. Despite the sexually dimorphic effect on acute intestinal lipid handling, Tg(fabp2a: EGFP - nr1h3) adults of both sexes are protected from high cholesterol diet (HCD)- induced hepatic lipid accumulation, while nr1h3(-/-) mutants are sensitive to the effects of HCD challenge. These data indicate that intestinal Lxr activity dampens the pace of intestinal lipid transport cell-autonomously. Selective activation of intestinal Lxrα holds therapeutic promise.
28536535	8	18	Intestinal	T017	UMLS:C0021853
28536535	19	23	LXRα	T103	UMLS:C0297439
28536535	27	37	Regulating	T038	UMLS:C1327622
28536535	52	57	Lipid	T103	UMLS:C0023779
28536535	72	76	Diet	T168	UMLS:C0012155
28536535	87	107	Hypercholesterolemia	T038	UMLS:C0020443
28536535	112	119	Hepatic	T082	UMLS:C0205054
28536535	120	138	Lipid Accumulation	T033	UMLS:C0333574
28536535	153	167	hyperlipidemia	T038	UMLS:C0020473
28536535	185	199	cardiovascular	T082	UMLS:C3887460
28536535	200	211	risk factor	T033	UMLS:C0035648
28536535	225	244	therapeutic options	T058	UMLS:C0683525
28536535	250	267	Liver X receptors	T103	UMLS:C4277606
28536535	269	273	Lxrs	T103	UMLS:C4277606
28536535	279	304	nuclear hormone receptors	T103	UMLS:C0887829
28536535	310	318	regulate	T038	UMLS:C1327622
28536535	319	330	cholesterol	T103	UMLS:C0008377
28536535	331	342	elimination	T038	UMLS:C0221102
28536535	371	381	regulating	T038	UMLS:C1327622
28536535	386	396	absorption	T038	UMLS:C0443214
28536535	401	409	handling	T033	UMLS:C1832073
28536535	413	425	dietary fats	T103	UMLS:C0012171
28536535	496	506	intestinal	T017	UMLS:C0021853
28536535	507	511	Lxrα	T103	UMLS:C0297439
28536535	529	539	intestinal	T017	UMLS:C0021853
28536535	540	545	lipid	T103	UMLS:C0023779
28536535	546	555	transport	T038	UMLS:C0005528
28536535	563	567	Lxrα	T017	UMLS:C1417824
28536535	568	576	knockout	T038	UMLS:C1522225
28536535	578	588	nr1h3(-/-)	T017	UMLS:C1417824
28536535	594	603	intestine	T017	UMLS:C0021853
28536535	614	618	Lxrα	T017	UMLS:C1417824
28536535	619	634	over-expressing	T038	UMLS:C0017262
28536535	639	645	fabp2a	T017	UMLS:C1333525
28536535	647	651	EGFP	T017	UMLS:C0017337
28536535	654	659	nr1h3	T017	UMLS:C1417824
28536535	662	671	zebrafish	T204	UMLS:C0043457
28536535	707	712	lipid	T103	UMLS:C0023779
28536535	728	740	live imaging	T058	UMLS:C0011923
28536535	744	750	larvae	T204	UMLS:C0023047
28536535	769	776	methods	T170	UMLS:C0025663
28536535	825	836	cholesterol	T103	UMLS:C0008377
28536535	837	844	dietary	T168	UMLS:C0012155
28536535	845	854	challenge	T058	UMLS:C0805586
28536535	909	919	nr1h3 gene	T017	UMLS:C1417824
28536535	947	967	hypercholesterolemia	T038	UMLS:C0020443
28536535	972	979	hepatic	T082	UMLS:C0205054
28536535	980	998	lipid accumulation	T033	UMLS:C0333574
28536535	1000	1015	Over-expression	T038	UMLS:C1171362
28536535	1019	1023	Lxrα	T017	UMLS:C1417824
28536535	1031	1040	intestine	T017	UMLS:C0021853
28536535	1052	1061	transport	T038	UMLS:C0005528
28536535	1074	1080	lipids	T103	UMLS:C0023779
28536535	1084	1090	larvae	T204	UMLS:C0023047
28536535	1098	1106	deletion	T038	UMLS:C0017260
28536535	1110	1114	Lxrα	T103	UMLS:C0297439
28536535	1137	1142	lipid	T103	UMLS:C0023779
28536535	1143	1152	transport	T038	UMLS:C0005528
28536535	1167	1175	wildtype	T017	UMLS:C1883559
28536535	1176	1182	larvae	T204	UMLS:C0023047
28536535	1206	1209	Lxr	T103	UMLS:C4277606
28536535	1210	1217	agonist	T103	UMLS:C2987634
28536535	1218	1237	hyodeoxycholic acid	T103	UMLS:C0063208
28536535	1263	1273	intestinal	T017	UMLS:C0021853
28536535	1274	1279	lipid	T103	UMLS:C0023779
28536535	1280	1289	transport	T038	UMLS:C0005528
28536535	1293	1299	larvae	T204	UMLS:C0023047
28536535	1317	1325	deletion	T038	UMLS:C0017260
28536535	1329	1333	Lxrα	T017	UMLS:C1417824
28536535	1346	1356	intestinal	T017	UMLS:C0021853
28536535	1357	1366	transport	T038	UMLS:C0005528
28536535	1379	1385	lipids	T103	UMLS:C0023779
28536535	1415	1421	plasma	T031	UMLS:C0032105
28536535	1422	1440	Lipoprotein lipase	T103	UMLS:C0023816
28536535	1442	1445	Lpl	T103	UMLS:C0023816
28536535	1447	1455	activity	T038	UMLS:C0243102
28536535	1497	1502	blood	T031	UMLS:C0005767
28536535	1503	1518	triacylglycerol	T103	UMLS:C0041004
28536535	1520	1523	TAG	T103	UMLS:C0041004
28536535	1583	1593	intestinal	T017	UMLS:C0021853
28536535	1594	1599	lipid	T103	UMLS:C0023779
28536535	1600	1608	handling	T033	UMLS:C1832073
28536535	1613	1619	fabp2a	T017	UMLS:C1333525
28536535	1621	1625	EGFP	T017	UMLS:C0017337
28536535	1628	1633	nr1h3	T017	UMLS:C1417824
28536535	1712	1719	hepatic	T082	UMLS:C0205054
28536535	1720	1738	lipid accumulation	T033	UMLS:C0333574
28536535	1746	1756	nr1h3(-/-)	T017	UMLS:C1417824
28536535	1757	1764	mutants	T038	UMLS:C0596988
28536535	1801	1810	challenge	T058	UMLS:C0805586
28536535	1837	1847	intestinal	T017	UMLS:C0021853
28536535	1848	1851	Lxr	T103	UMLS:C4277606
28536535	1881	1891	intestinal	T017	UMLS:C0021853
28536535	1892	1897	lipid	T103	UMLS:C0023779
28536535	1898	1907	transport	T038	UMLS:C0005528
28536535	1951	1961	intestinal	T017	UMLS:C0021853
28536535	1962	1966	Lxrα	T103	UMLS:C0297439